Data center cable management market was valued at $6.2 billion in 2025 and is projected to reach $14.6 billion by 2035, growing at a CAGR of 9.0% during the forecast Period (2026-2035). Increased domestic manufacturing of cabling components bolsters the supply of fiber and power cables, enabling the swift deployment and scaling of data center operations, which in turn drives market growth. Recent large-scale agreements and collaborations in the US illustrate this trend, highlighting the essential role of advanced optical fiber and connectivity solutions in supporting AI and cloud infrastructure. For instance, in January 2026, Corning Inc. and Meta Platforms, Inc. entered a multi-year agreement worth up to $6 billion to advance data center development in the US. Corning provided Meta with advanced optical fiber, cable, and connectivity solutions necessary for Meta's technology and AI projects. Furthermore, Corning is set to expand its manufacturing capabilities in North Carolina, particularly in its Hickory optical cable facility, with Meta as the main customer.

Data center accelerator market was valued at $28.5 billion in 2025 and is projected to reach $123.1 billion by 2035, growing at a CAGR of 15.9% during the forecast Period (2026-2035). Advanced GPUs are increasingly driving AI inference performance, optimizing throughput for machine learning applications and supporting broader enterprise adoption of AI technologies. These developments not only improve computational efficiency however stimulate growth in the global data center accelerator market, as organizations invest in high-performance hardware to meet evolving AI workload demands.

US EaaS market is projected to grow from $27.1 billion in 2025 and is projected to reach $83.0 billion by 2035, growing at a CAGR of 10.7% during the forecast period 2026-2035. The US Energy as a Service market is gaining momentum as organizations seek alternatives to capital-intensive energy investments. Companies are shifting toward service-based models that convert fixed costs into predictable operating expenses. This transition is supported by the need for better control over energy consumption and long-term cost visibility. Businesses are also focusing on reducing exposure to energy price fluctuations through structured service agreements. Increased adoption of distributed energy systems is contributing to market expansion across commercial and industrial sectors. Providers are offering integrated solutions that combine energy supply with performance monitoring. Digital tools are improving visibility into usage patterns and operational efficiency. The growing emphasis on sustainability goals is reinforcing demand for such solutions. These factors are shaping a steady and structured growth environment in the US market.

Global zinc gluconate market is projected to grow from $1.8 billion in 2025 and is projected to reach $3.3 billion by 2035, growing at a CAGR of 6.1% during the forecast period 2026-2035. The global zinc gluconate market is expected to achieve a valuation of $3.3 billion by 2035 as demand grows across health-focused applications. Increased public awareness of micronutrient roles in immune and metabolic health is fueling uptake of zinc gluconate in supplements and fortified products. Consumption patterns show steady expansion in both mature and emerging regions as consumers adopt preventive health behaviors. Manufacturers are scaling production capacities in response to this sustained interest. Regulatory bodies in multiple countries are emphasizing quality and safety standards for nutritional ingredients. Research into bioavailability and formulation improvements is advancing product development. Investment in distribution networks is helping expand market presence across retail and online channels. This combination of demand drivers is supporting consistent market expansion toward the forecasted value.

Global topiramate market is projected to grow from $1.3 billion in 2025 and is projected to reach $2.2 billion by 2035, growing at a CAGR of 5.0% during the forecast period 2026-2035. The global Topiramate market is experiencing steady growth due to the increasing prevalence of neurological disorders and migraine conditions. Improved diagnostic capabilities have led to earlier detection and more consistent treatment. Generic formulations are expanding access in cost-sensitive regions, driving prescription volumes. Manufacturers are focusing on scaling production and improving supply chain efficiency to meet demand. Regulatory approvals for both branded and generic products have facilitated wider availability. Healthcare providers are adopting evidence-based protocols, which enhance treatment adherence. Investment in patient awareness campaigns is contributing to market expansion. The combination of rising patient numbers and accessible treatments is sustaining revenue growth globally.

Global EaaS market is projected to grow to $81.6 billion in 2025 and is projected to reach $225.5 billion by 2035, growing at a CAGR of 10.7% during the forecast period 2026-2035. The Energy as a Service market is evolving as organizations shift toward asset-light operating models and predictable cost structures. Many enterprises prefer long-term energy contracts that align payments with actual consumption and performance outcomes. Digital monitoring systems are becoming standard, enabling continuous visibility into energy use and operational efficiency. This shift supports better decision-making and reduces unexpected downtime. Regulatory frameworks in multiple regions are reinforcing accountability in energy usage and emissions management. Companies are also focusing on integrating distributed energy resources within service agreements. This includes on-site generation and storage managed under contractual models. Such developments are gradually reshaping how energy is procured and managed across industries.

Global drone market is projected to grow from $30.1 billion in 2025 and is projected to reach $78.6 billion by 2035, growing at a CAGR of 10.1% during the forecast period 2026-2035. The global drone market is on a clear growth path, moving from a base of thirty-one billion US dollars in 2025 toward an estimated seventy?eight point six billion US dollars by 2035. Businesses are increasing the use of unmanned aerial systems to improve efficiency in operations that were once slow and labor-intensive. Cost reductions in sensors and batteries are making commercial drone technologies more accessible to a broader range of industries. At the same time, regulatory frameworks are evolving and allowing more flights beyond visual line of sight. Investment in software applications that support automated missions is rising. A broader set of payload options is expanding what drones can measure and monitor. Enterprise buyers are planning longer-term replacements and upgrades for their fleets. The shift toward data-driven decision-making is supporting the adoption of aerial platforms across sectors.

Global alpha 2C adrenergic receptor market is projected to grow from $225.1 million in 2025 and is projected to reach $468.3 million by 2035, growing at a CAGR of 7.6% during the forecast period 2026-2035. The global alpha 2C adrenergic receptor market is experiencing growth driven by increased focus on receptor-specific therapies for neurological and ocular conditions. Ongoing research is enabling the development of more effective and precise treatments. Pharmaceutical companies are investing in clinical trials to expand product indications and improve efficacy. Awareness among healthcare providers and patients is gradually supporting adoption. Expanding healthcare infrastructure in major regions allows faster distribution and commercialization. Technological advancements in formulation and delivery methods are enhancing therapeutic outcomes. Collaborative efforts between research institutions and manufacturers are strengthening the development pipeline. Regulatory support for innovative drugs is creating a favorable environment for market expansion.

Global CXC Chemokine Receptor market is projected to grow from $1.1 billion in 2025 to reach $2.7 billion by 2035, and is growing at a CAGR of 9.2% during the forecast period 2026-2035. The global CXC chemokine receptor market is experiencing consistent growth due to increasing adoption of targeted therapies in oncology and rare diseases. Advances in biotechnology and molecular research are enabling the development of more specific receptor modulators. Investment in clinical trials and regulatory approvals has accelerated product availability across multiple regions. Collaborations between pharmaceutical companies and research institutions are enhancing innovation and speeding up commercialization. Patient awareness and physician adoption are improving the uptake of these therapies. Expansion into emerging markets is also contributing to revenue growth. The focus on CXCR4 and CXCR1/2 antagonists is driving significant clinical and commercial activity. Overall, the market is benefiting from technological advances and strategic initiatives.

Global PPP market is projected to grow from $10.4 billion in 2025 and is projected to reach $15.5 billion by 2035, growing at a CAGR of 4.1% during the forecast period 2026-2035. Shifts in treatment patterns are influencing how products are positioned across the market. There is a gradual move toward long-term management of recurring gastrointestinal conditions, which supports steady prescription volumes. Physicians are paying closer attention to safety profiles, especially for prolonged use, which is shaping prescribing behavior. Demand is also supported by the growing elderly population that requires continuous therapy. Generic formulations continue to gain traction due to cost considerations and wider availability. Manufacturers are focusing on optimizing production efficiency to remain competitive in a price-sensitive environment. These developments reflect a stable yet evolving market structure.